VerbatimParliament, as it happens

Liothyronine

Asked by Anna SabineLiberal DemocratDepartment of Health and Social CareTabled Answered 22 April 2026UIN 127691

The question

To ask the Secretary of State for Health and Social Care, what discussions he has had with Integrated Care Boards on policies on liothyronine, including requiring Exceptional/Individual Funding Requests and applying bans on new patients; and if he will issue guidance to prevent restrictions where NHS England guidance supports its use in some patients.

Answered by Dr Zubir Ahmed

The Department has not held any discussions with integrated care boards regarding their policies on liothyronine. NHS England regional teams have distributed the Items that should not be prescribed in primary care policy guidance to local healthcare systems. These systems are responsible for ensuring that prescribing practices follow the guidance provided.

Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →

Open this question in Verbatim →

Every written question, searchable

155,000 questions tabled since the election, with the answer each department gave — and the ones still unanswered, with the clock running. Free to search.

Search written questions →Read on Verbatim